A new study hopes to produce a catalogue of human genetic variation and assess the burden of noncommunicable diseases in 100,000 adults in Nigeria.
Academic rigour, journalistic flair
Articles on Science and innovation for development
Displaying 1 - 20 of 205 articles
Drug discovery research in Africa receives modest but essential international funding through philanthropic foundations and selected pharmaceutical companies.
Molecular research is expensive, but worth it because of the burden of disease that it could relieve.
Before the COVID pandemic, efforts to address the challenge of limited vaccine production on the continent yielded little success.
Mobile health or mHealth is an appealing way to reach adolescents because it offers opportunities to deliver and monitor health interventions at a much lower cost.
As a major contributor of knowledge, Nigeria could make giant strides in nanotechnology – which in turn could help various industries blossom.
The African BioGenome Project is a pan-African project that seeks to sequence Africa’s endemic and indigenous plants and animals.
There remains a crucial need for animal models to understand health and disease and to develop medicines.
In 2020 TB case detection fell by almost 20% and mortality rose for the first time in a decade. These setbacks are directly attributable to the COVID-19 pandemic.
With the manufacturing capacity and access to relevant technology, African countries can reduce their dependency on international manufacturers for vaccines.
Saponins from plants can destroy viruses and other microorganisms in the same way commercial soaps and detergents do.
Young academies, which generally represent early career scientists, fared far better than their senior counterparts - a promising sign for the future.
As a disease progresses, so too must the underlying data and reporting improve to manage the progression of the outbreak.
To attain a new health order, African governments need to bolster investment in research and development, innovation and manufacturing of health tools.
At this stage, we cannot say anything about the severity of cases with Omicron - either in primary or reinfections.
To be effective, vaccine formulas need to cover all emergent strains. But there are still plenty of unknowns.
Manufacturing is just one part of the vaccine ecosystem. It’s the health system that delivers vaccines and people must be willing to take them.
The need of the moment is for low- and middle-income countries to improve their own manufacturing capabilities.
Afrigen will be a technology transfer and training hub: it shares technology and develops skills specifically around how to produce a safe, effective and affordable mRNA vaccine.
Continuous growth of energy production and consumption, even from low carbon energy sources, could create more problems than solutions.
Job Board
-
Astronomy & Space - Women and gender diverse recruitment - 10 Positions!
-
Dean of Medicine and Head of the Macquarie Medical School
-
Professor/Associate Professor or Senior Lecturer in Physiotherapy
-
Business Manager
-
Associate Professor or Professor in Criminology
Top contributors
-
Researcher, Lecturer, Attorney, University of KwaZulu-Natal
-
Professor of the Practice of International Development, Harvard Kennedy School
-
Professor of medicine and deputy director of the Desmond Tutu HIV Centre at the Institute of Infectious Disease and Molecular Medicine, University of Cape Town
-
Professor of Organic Chemistry, Neville Isdell Chair in African-centric Drug Discovery & Development, and Director of the Holistic Drug Discovery and Development (H3D) Centre, University of Cape Town
-
Dean Faculty of Health Sciences and Professor of Vaccinology at University of the Witwatersrand; and Director of the SAMRC Vaccines and Infectious Diseases Analytics Research Unit, University of the Witwatersrand
-
Director, Institute for Cellular and Molecular Medicine & SAMRC Extramural Unit for Stem Cell Research & Therapy, University of Pretoria
-
Director, Cochrane South Africa, South African Medical Research Council
-
Post Doctoral Fellow, University of KwaZulu-Natal
-
Professor in Biochemistry, Genetics and Microbiology, and Professor at Future Africa, University of Pretoria, University of Pretoria
-
Associate Professor, Cape Peninsula University of Technology
-
Tutorial Fellow, School of Medicine, University of Nairobi, University of Nairobi
-
Head of the Division of Pulmonology, University of Cape Town
-
Head of the Centre of Excellence for Biomedical TB Research, University of the Witwatersrand
-
Associate Professor at the University of Pretoria and Co-ordinator of the South African SDG Hub, University of Pretoria
-
Adjunct Professor, Nelson Mandela School of Public Governance, University of Cape Town
